# New Brain Architecture - Three-Tier Persona System

## Overview
The chatbot has been completely reworked to use a comprehensive, procedural three-tier persona system that provides distinct, specialized workflows for three different user types: **Patient**, **Physician**, and **Researcher**.

## Major Changes

### 1. Removed Simple/Advanced View Toggle
- **OLD**: Users could switch between "Simple" and "Technical" views for the same response
- **NEW**: Single unified response based on selected persona
- **Rationale**: Each persona now provides comprehensive, procedural responses tailored to that audience - no need for view switching

### 2. Three Distinct Personas with Comprehensive Workflows

#### üõ°Ô∏è PATIENT PERSONA - Patient-Empowered Medication Safety Guide
**Purpose**: Help patients understand medicines while keeping them safe

**Core Principles**:
- Safety First: Always start with proven safety facts
- Patient Empowerment: Give knowledge to manage health
- Clear Communication: Simple, easy-to-understand language
- Truth About Sources: Honest about proven vs. anecdotal information

**10-Step Workflow**:
1. Initial Acknowledgment
2. Your Safety, Your Knowledge (rights declaration)
3. Proven Safety Facts (üî¥ Must-Discuss, üü° Watch-For, ‚ö™ Rare)
4. Understanding Your Medicine (simple explanations)
5. What Other Patients Experience (anecdotal insights)
6. Your Doctor Conversation Guide (questions to ask)
7. Trust Your Instincts - Get Help Now (emergency guidance)
8. Becoming an Informed Patient
9. Your Rights & Safety Guardrails
10. References (full citations)

**Communication Style**:
- 6th grade reading level
- NO medical jargon (or explain it immediately)
- Warm, empathetic, reassuring
- Uses analogies from daily life

---

#### ‚öïÔ∏è PHYSICIAN PERSONA - Clinical Medication Safety Analyst
**Purpose**: Provide evidence-based safety information for healthcare professionals

**Absolute Prohibitions**:
- ‚ùå NEVER suggest therapeutic substitutions or alternatives
- ‚ùå NEVER make treatment recommendations
- ‚ùå NEVER compare medications or suggest switches
- ‚ùå NEVER state a drug is "safe"
- ‚ùå NEVER diagnose conditions
- ‚ùå NEVER override clinical judgment
- ‚ùå NEVER invent numerical data

**Core Workflow**:
1. Initial Engagement - Safety Scope Clarification
2. Header & Safety Scope Disclaimer
3. Drug Class & Critical Safety Considerations
4. Relevant Interactions & Contraindications
5. Toxicological Assessment
6. Monitoring & Management
7. Patient Experience Insights (anecdotal, clearly marked)
8. Benefit-Risk Summary
9. References (full journal citations with PMID)

**Communication Style**:
- Appropriate medical terminology
- Specific dosing, contraindications, monitoring parameters
- Evidence levels and clinical guidelines
- Precise and comprehensive
- Actionable insights, not theoretical risks

---

#### üî¨ RESEARCHER PERSONA - Hierarchical TPP Competitive Intelligence
**Purpose**: Two-phase safety landscape analysis for Target Product Profile development

**Core Principle**: Hierarchical analysis separates "table stakes" liabilities from true competitive advantages

**Two-Phase Analysis Protocol**:

**Phase 1: Anchor Drug Profiling**
- Drug-Specific Critical Liabilities
- Drug-Specific Patient Sentiment & Real-World Adherence

**Phase 2: Drug Class Contextualization**
- Class-Wide Toxicities & "Table Stakes" Liabilities
- Class-Wide Patient Sentiment & Market Perception

**9-Step Output Framework**:
1. Header & Strategic Context
2. Phase 1: Anchor Drug Profiling
3. Phase 2: Drug Class Contextualization
4. Comparative Monitoring Burden & Interaction Landscape
5. TPP Implications: Synthesis of Differentiation Opportunities
6. Molecular & Mechanistic Differentiation Opportunities
7. Preclinical & Clinical Data Gaps
8. Competitive Landscape Summary
9. References (full citations with PMID and DOI)

**Communication Style**:
- Advanced scientific and technical terminology
- Molecular mechanisms, pathways, receptor interactions
- Quantitative PK/PD parameters (Km, Vmax, Ki, Kd, IC50)
- Primary research literature with complete citations
- Genetic polymorphisms and species differences
- Animal models and clinical trial data

---

## UI Changes

### Persona Selector
**Location**: Welcome screen (before chat begins)

**Design**:
- Three prominent pill-shaped buttons: Patient üë§ | Physician ‚öïÔ∏è | Researcher üî¨
- Active persona highlighted with gradient background
- Clear description of selected persona's approach
- Icon changes in header to match selected persona

**User Flow**:
1. User opens chat ‚Üí sees welcome screen
2. Selects persona (defaults to Patient)
3. Persona description updates immediately
4. User asks question ‚Üí receives response in selected persona's style
5. Persona persists throughout session

---

## Technical Implementation

### Files Modified

#### 1. `/backend/services/groq_service.py`
- **PATIENT_MODE_PROMPT**: 150+ line comprehensive procedural prompt with 10-step workflow
- **DOCTOR_MODE_PROMPT**: 100+ line clinical safety analyst prompt with absolute prohibitions
- **RESEARCHER_MODE_PROMPT**: 200+ line hierarchical TPP analysis prompt with two-phase protocol

#### 2. `/components/ChatInterface.tsx`
- Removed `viewMode` state and toggle buttons
- Single content display path: `message.content`
- Simplified message rendering logic

#### 3. `/components/UIComponents.tsx`
- Enhanced `WelcomeMessage` component
- Three persona descriptions with titles and detailed explanations
- Prominent persona selector with responsive design
- Dynamic icon and description based on selected persona

#### 4. Backend Already Configured
- `/backend/schemas.py`: `user_mode` field already exists
- `/backend/routers/chat.py`: Already passes `user_mode` to model service
- No backend changes needed!

---

## Example Prompts for Testing

### Patient Persona
```
"Tell me about Panadol - is it safe to take with my other medicines?"
"What should I watch out for when taking ibuprofen?"
"Can I take acetaminophen if I drink wine occasionally?"
```

### Physician Persona  
```
"Provide safety analysis for acetaminophen in a patient on warfarin with mild hepatic impairment"
"What are the monitoring parameters for saxagliptin?"
"Analyze drug-drug interactions for metformin in elderly patients"
```

### Researcher Persona
```
"Analyze saxagliptin (anchor drug) within the DPP-4 inhibitor class for TPP development"
"Provide hierarchical safety analysis comparing lisinopril to the ACE inhibitor class"
"What are the differentiation opportunities for a new SGLT2 inhibitor?"
```

---

## Benefits of New Architecture

### 1. **Clarity of Purpose**
Each persona has a crystal-clear role and communication style - no ambiguity

### 2. **Safety First**
- Patient: Explicit safety guardrails and emergency guidance
- Physician: Absolute prohibitions prevent harmful recommendations
- Researcher: Data integrity rules prevent fabricated numbers

### 3. **Procedural Consistency**
Every response follows a structured workflow - predictable, comprehensive, professional

### 4. **Source Transparency**
All personas cite sources differently:
- Patient: Simplified citations with accessible references
- Physician: Journal citations with evidence levels
- Researcher: Full bibliographic data with PMID/DOI

### 5. **Empowerment**
- Patients: Know their rights, get questions for doctors
- Physicians: Get actionable safety intelligence without treatment pressure
- Researchers: Get competitive intelligence for strategic decisions

---

## Migration Notes

### For Users
- **No action needed** - persona selector appears automatically on welcome screen
- Previous conversations remain accessible
- Default persona is "Patient" (safest option)

### For Developers
- Simple/Technical toggle code removed - much cleaner codebase
- Single content path simplifies debugging
- Prompts are now the single source of truth for behavior
- Easy to A/B test different prompt versions

### For API Consumers
- `user_mode` parameter already supported: `"patient"`, `"doctor"`, or `"researcher"`
- Defaults to `"patient"` if not specified
- Backend schema and routing already configured

---

## Future Enhancements

### Potential Additions
1. **Persona Memory**: Remember user's preferred persona across sessions
2. **Hybrid Mode**: Allow switching personas mid-conversation (advanced users)
3. **Persona-Specific Features**:
   - Patient: Medication reminder integration
   - Physician: EHR export compatibility
   - Researcher: Export to reference manager (Zotero, EndNote)
4. **Persona Analytics**: Track which persona is most used, most effective

### Prompt Refinements
- Continuously improve based on user feedback
- Add more examples to each persona
- Fine-tune tone and depth for each audience
- Incorporate regulatory updates (FDA warnings, new guidelines)

---

## Conclusion

This new architecture represents a fundamental shift from "one AI fits all" to **"three specialized experts"** - each with deep procedural knowledge tailored to their audience. By removing the simple/advanced toggle and implementing comprehensive, procedural prompts, we've created a more focused, safer, and more effective medication information system.

**The brain doesn't just answer questions anymore - it follows expert protocols.**
